UBS Group’s RXO RXO Stock Holding History

UBS Group’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,100	Closed	-$311K	–	10268
2022 Q4	$311K	Buy	+18,100	New	+$321K	﹤0.01%	5085

Other funds holding RXO

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

UBS Group's RXO Position: Q2 2026 in Review

UBS Group reduced its RXO (RXO) stake by 57% in Q2 2026, selling an estimated $26.7M and leaving 909,106 shares worth $25.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2442.

UBS Group first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $45.4M in Q4 2024. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

UBS Group held 909,106 shares of RXO worth $25.1M as of Q2 2026.
UBS Group sold 1,208,185 RXO shares in Q2 2026, an estimated $26.7M.
RXO made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2442 holding.
UBS Group first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
UBS Group's RXO position peaked at $45.4M in Q4 2024.
304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.